|
Volumn 28, Issue 1, 2008, Pages 76-77
|
Stepwise decline in visual field after serial sildenafil use
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMLODIPINE;
PHOSPHODIESTERASE V INHIBITOR;
PROSTAGLANDIN E1;
SILDENAFIL;
TADALAFIL;
VARDENAFIL;
ADULT;
AFFERENT PUPILLARY DEFECT;
CASE REPORT;
COLOR VISION DEFECT;
DRUG WITHDRAWAL;
ERECTILE DYSFUNCTION;
EYE EXAMINATION;
HUMAN;
HYPERTENSION;
ISCHEMIC OPTIC NEUROPATHY;
LETTER;
MALE;
NOSE EDEMA;
OPHTHALMOSCOPY;
PRIORITY JOURNAL;
SEDIMENTATION RATE;
SINGLE DRUG DOSE;
VISUAL ACUITY;
VISUAL FIELD;
VISUAL FIELD DEFECT;
AMLODIPINE;
ANTIHYPERTENSIVE AGENTS;
DISEASE PROGRESSION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG INTERACTIONS;
ERECTILE DYSFUNCTION;
HUMANS;
HYPERTENSION;
MALE;
MIDDLE AGED;
OPTIC NERVE;
OPTIC NEUROPATHY, ISCHEMIC;
PHOSPHODIESTERASE INHIBITORS;
PIPERAZINES;
PROSTATECTOMY;
PROSTATIC NEOPLASMS;
PURINES;
RETINAL ARTERY;
RISK FACTORS;
SULFONES;
TIME;
VISION, LOW;
|
EID: 40949126525
PISSN: 10708022
EISSN: None
Source Type: Journal
DOI: 10.1097/WNO.0b013e31816743da Document Type: Letter |
Times cited : (18)
|
References (7)
|